At IASSIDD, every activity, communication, and advocacy effort is firmly anchored in our mission: to advance knowledge, research, and practice in genuine partnership with people with intellectual and developmental disabilities. We recognise that advocacy is essential to promoting the rights and well-being of people with intellectual and developmental disabilities, and we are committed to engaging in issue advocacy, public education, and policy analysis—always when these actions are directly aligned with our mission and grounded in robust research and evidence.
IASSIDD is the lead scientific organisation internationally on matters relating to intellectual and developmental disability. Our membership and professional alliances include lead experts in disabilities from around the world. IASSIDD’s public advocacy voice is to promote and protect the human rights and well-being of all people with intellectual and developmental disabilities in all nations. IASSIDD is a non-politically and non-ideologically aligned international organisation.
IASSIDD Opposes Human Cost from Military Conflict
The International Association for the Scientific Study of Intellectual and Developmental Disabilities (IASSIDD) firmly opposes the maltreatment of all children and adults with intellectual and developmental disabilities, as well as their families and supporters, that results from human -generated political violence and military conflict.
The International Association for the Scientific Study of Intellectual and Developmental Disabilities (IASSIDD) supports the FDA ban of the use of contingent electric shock with people with intellectual and developmental disabilities
IASSIDD Opposes Electric Skin Shock as Treatment
The International Association for the Scientific Study of Intellectual and Developmental Disabilities (IASSIDD) strongly opposes administering electric skin shock to individuals with intellectual and developmental disabilities who have challenging behaviour.
Zika Virus
IASSIDD supports strong and immediate worldwide action to develop a vaccine and take other safe
measures to prevent the occurrence of developmental disabilities in children caused by in utero Zika virus infection.